Tanaka S - Search Results

1

Upregulation of protein tyrosine phosphatase type IVA member 3 (PTP4A3/PRL-3) is associated with tumor differentiation and a poor prognosis in human hepatocellular carcinoma.

Mayinuer A, Yasen M, Mogushi K, Obulhasim G, Xieraili M, Aihara A, Tanaka S, Mizushima H, Tanaka H, Arii S. Mayinuer A, et al. Among authors: tanaka s, tanaka h. Ann Surg Oncol. 2013 Jan;20(1):305-17. doi: 10.1245/s10434-012-2395-2. Epub 2012 Oct 13. Ann Surg Oncol. 2013. PMID: 23064776 Free PMC article.

2

Clinical significance of vascular endothelial growth factor C expression and angiogenesis at the deepest invasive site of advanced colorectal carcinoma.

Furudoi A, Tanaka S, Haruma K, Kitadai Y, Yoshihara M, Chayama K, Shimamoto F. Furudoi A, et al. Among authors: tanaka s. Oncology. 2002;62(2):157-66. doi: 10.1159/000048262. Oncology. 2002. PMID: 11914602

3

The role of MTA1 gene expression in human hepatocellular carcinoma.

Hamatsu T, Rikimaru T, Yamashita Y, Aishima S, Tanaka S, Shirabe K, Shimada M, Toh Y, Sugimachi K. Hamatsu T, et al. Among authors: tanaka s. Oncol Rep. 2003 May-Jun;10(3):599-604. Oncol Rep. 2003. PMID: 12684630

4

Induction of angiopoietin-2 gene expression by COX-2: a novel role for COX-2 inhibitors during hepatocarcinogenesis.

Tanaka S, Wands JR, Arii S. Tanaka S, et al. J Hepatol. 2006 Jan;44(1):233-5. doi: 10.1016/j.jhep.2005.09.012. Epub 2005 Nov 2. J Hepatol. 2006. PMID: 16290311 No abstract available.

5

[Novel molecular-targeting peptide therapy for pancreatic cancer metastasis].

Tanaka S, Nakamura N, Kawamura T, Teramoto K, Arii S. Tanaka S, et al. Nihon Rinsho. 2006 Jan;64 Suppl 1:283-7. Nihon Rinsho. 2006. PMID: 16457267 Review. Japanese. No abstract available.

6

Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis.

Tanaka S, Pero SC, Taguchi K, Shimada M, Mori M, Krag DN, Arii S. Tanaka S, et al. J Natl Cancer Inst. 2006 Apr 5;98(7):491-8. doi: 10.1093/jnci/djj105. J Natl Cancer Inst. 2006. PMID: 16595785

7

Current status and perspective of antiangiogenic therapy for cancer: hepatocellular carcinoma.

Tanaka S, Arii S. Tanaka S, et al. Int J Clin Oncol. 2006 Apr;11(2):82-9. doi: 10.1007/s10147-006-0566-5. Int J Clin Oncol. 2006. PMID: 16622743 Review.

8

Outcomes and recurrence of initially resectable hepatocellular carcinoma meeting milan criteria: Rationale for partial hepatectomy as first strategy.

Tanaka S, Noguchi N, Ochiai T, Kudo A, Nakamura N, Ito K, Kawamura T, Teramoto K, Arii S. Tanaka S, et al. J Am Coll Surg. 2007 Jan;204(1):1-6. doi: 10.1016/j.jamcollsurg.2006.10.004. Epub 2006 Nov 28. J Am Coll Surg. 2007. PMID: 17189106

9

Mucinous cystadenocarcinoma of the pancreas developing during hormone replacement therapy.

Tanaka S, Kawamura T, Nakamura N, Teramoto K, Arii S. Tanaka S, et al. Dig Dis Sci. 2007 May;52(5):1326-8. doi: 10.1007/s10620-006-9482-9. Epub 2007 Mar 20. Dig Dis Sci. 2007. PMID: 17372823

10

CREB3L4, INTS3, and SNAPAP are targets for the 1q21 amplicon frequently detected in hepatocellular carcinoma.

Inagaki Y, Yasui K, Endo M, Nakajima T, Zen K, Tsuji K, Minami M, Tanaka S, Taniwaki M, Itoh Y, Arii S, Okanoue T. Inagaki Y, et al. Among authors: tanaka s. Cancer Genet Cytogenet. 2008 Jan 1;180(1):30-6. doi: 10.1016/j.cancergencyto.2007.09.013. Cancer Genet Cytogenet. 2008. PMID: 18068530

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,833 results

Search Page

Filters